|
Volumn 16, Issue 13, 1998, Pages 1295-
|
Not quite pharmacogenomics [1]
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN EXPRESSION;
BREAST CANCER;
DIAGNOSTIC TEST;
GENOTYPE;
HUMAN;
LETTER;
PHARMACOGENETICS;
PHENOTYPE;
PRIORITY JOURNAL;
BREAST TUMOR;
GENETICS;
GENOME;
NOTE;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
GENOME;
HUMANS;
PHARMACOGENETICS;
RECEPTOR, ERBB-2;
|
EID: 0031791656
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/4244 Document Type: Letter |
Times cited : (22)
|
References (0)
|